Meibomian gland loss exceeding 50% represents advanced meibomian gland dysfunction (MGD), where typical medical therapy (IPL, warm compresses, lid hygiene, medications) helps symptomatically but full gland regeneration is not expected with these alone.
Neurostimulation therapies (including intranasal, electrical, or external nerve stimulation) have shown benefits in increasing tear production and improving overall dry eye symptoms but offer limited evidence regarding direct regeneration of the lost meibomian gland structure.
Current Regenerative Therapies: Research into regenerative approaches such as exosome therapy, mesenchymal stem cell injections, and advanced radiofrequency devices shows promise in stimulating remaining gland function and potentially some regeneration, but these are still experimental and not established as standard care.
Next Steps
Continue prescribed maintenance IPL and medication treatment; these improve symptoms and may preserve remaining gland function, though they do not restore lost gland tissue.
Consider evaluation by a dry eye specialist for potential advanced therapies like thermal pulsation (LipiFlow), exosome therapy, or clinical trial participation, which may offer more benefit for severe gland loss based on emerging research.
Take regular screen breaks, use preservative-free lubricants, optimize room humidity, and wear protective eyewear to further reduce symptoms.
Health Tips
Be cautious about alternative therapies (including neurotherapy not backed by published research) for meibomian gland regeneration. Focus on proven medical treatments and seek multidisciplinary consult for persistent symptoms.
If symptoms worsen and interfere with work, document changes and discuss escalation of care options, including possible surgical or regenerative approaches with an expert.
In summary, there is no clinical evidence that Neurotherapy Lajpatrai Mehra NT regenerates meibomian glands, and you should continue with established management while keeping updated on new medical advancements